Home › Research › Treatments
The Cell and Molecular Pathology of Tau Protein in Alzheimer’s Disease
Francisco García‐Sierra, Benjamín Florán. Microscopy and Microanalysis, 2025-07-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
As a result of multiple phosphorylation, Tau undergoes early conformational changes involving the bending of the intact amino (N)-terminus over the third repeated domain, which in turn was evidenced by positive immunolabeling with the monoclonal antibody Alz-50 [2]. Besides this, ubiquitination was also observed in NFTs composed of D421-truncated Tau, which may indicate that two different pathways of proteolytic processing occur in a single molecule to promote its aggregation and insolubility in the neuronal cytoplasm [7]. In conclusion, this cascade of pathological molecular events happening in the tau protein may correlate better with the neuropathological progression of the disease. After 48 hours of transfection in neuroblastoma cells, we found remarkable alteration of the tubulin cytoskeleton, forming pericentric and perinuclear ring-shaped microtubule bundles [8].
What this study adds
Evidence grade: Low
This laboratory work describes molecular events in the tau protein, including phosphorylation-driven conformational changes and ubiquitination in neurofibrillary tangles, that may correlate better with neuropathological progression of the disease. It also reports altered tubulin cytoskeleton structure in neuroblastoma cells after transfection, which is early cell-based research and not a treatment finding.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
García‐Sierra, F., & Florán, B. (2025). The Cell and Molecular Pathology of Tau Protein in Alzheimer’s Disease. Microscopy and Microanalysis. https://doi.org/10.1093/mam/ozaf048.453
Vancouver
García‐Sierra F, Florán B. The Cell and Molecular Pathology of Tau Protein in Alzheimer’s Disease. Microscopy and Microanalysis. 2025. doi:10.1093/mam/ozaf048.453.
BibTeX
@article{garciasierra2025-c15ceeee,
author = {García‐Sierra, Francisco and Florán, Benjamín},
title = {{The Cell and Molecular Pathology of Tau Protein in Alzheimer’s Disease}},
journal = {Microscopy and Microanalysis},
year = {2025},
doi = {10.1093/mam/ozaf048.453},
url = {https://doi.org/10.1093/mam/ozaf048.453}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- As a result of multiple phosphorylation, Tau undergoes early conformational changes involving the bending of the intact amino (N)-terminus over the third repeated domain, which in turn was evidenced by positive immunolabeling with the monoclonal antibody Alz-50 [2].
- Besides this, ubiquitination was also observed in NFTs composed of D421-truncated Tau, which may indicate that two different pathways of proteolytic processing occur in a single molecule to promote its aggregation and insolubility in the neuronal cytoplasm [7].
- In conclusion, this cascade of pathological molecular events happening in the tau protein may correlate better with the neuropathological progression of the disease.
- After 48 hours of transfection in neuroblastoma cells, we found remarkable alteration of the tubulin cytoskeleton, forming pericentric and perinuclear ring-shaped microtubule bundles [8].
Why it matters
This laboratory work describes molecular events in the tau protein, including phosphorylation-driven conformational changes and ubiquitination in neurofibrillary tangles, that may correlate better with neuropathological progression of the disease. It also reports altered tubulin cytoskeleton structure in neuroblastoma cells after transfection, which is early cell-based research and not a treatment finding.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Evidence strengthLow
How this study scored 29/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Microscopy and Microanalysis) |
| Journal's citation record | 1 / 4 | Microscopy and Microanalysis: journal h-index 95 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Benjamín Florán: h-index 34 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional: institution h-index 542 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 29 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Treatments from nearby years
Also tagged “phosphorylated”
732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.